A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer

IMPORTANCE: Moving to multigene testing for all women with breast cancer (BC) could identify many more mutation carriers who can benefit from precision prevention. However, the cost-effectiveness of this approach remains unaddressed. OBJECTIVE: To estimate incremental lifetime effects, costs, and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li, Brentnall, Adam, Patel, Shreeya, Buist, Diana S. M., Bowles, Erin J. A., Evans, D. Gareth R., Eccles, Diana, Hopper, John, Li, Shuai, Southey, Melissa, Duffy, Stephen, Cuzick, Jack, dos Santos Silva, Isabel, Miners, Alec, Sadique, Zia, Yang, Li, Legood, Rosa, Manchanda, Ranjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777250/
https://www.ncbi.nlm.nih.gov/pubmed/31580391
http://dx.doi.org/10.1001/jamaoncol.2019.3323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777250/
https://www.ncbi.nlm.nih.gov/pubmed/31580391
http://dx.doi.org/10.1001/jamaoncol.2019.3323

Ejemplares similares